Yamamoto Masayoshi, Seo Yoshihiro, Ishizu Tomoko, Kawamatsu Naoto, Sato Kimi, Sugano Akinori, Atsumi Akiko, Harimura Yoshie, Machino-Ohtsuka Tomoko, Sakamaki Fumiko, Aonuma Kazutaka
Cardiovascular Division, Faculty of Clinical Medicine, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
J Echocardiogr. 2015 Mar;13(1):20-6. doi: 10.1007/s12574-014-0234-0. Epub 2014 Dec 3.
Cardiac resynchronization therapy (CRT) may improve left ventricular (LV) diastolic dysfunction as well as systolic dysfunction. Diastolic dysfunction is a key for prognosis in patients with heart failure; therefore, we aimed to clarify the impact of CRT on diastolic function and prognosis.
In 67 patients who underwent CRT, LV diastolic function was assessed by pulsed Doppler transmitral flow pattern at baseline and 1 week after CRT, and classified into restrictive filling pattern (RFP) and non-RFP groups. Volume responders were defined by reduction of LV end-systolic volume >15% at 6 months after CRT. The clinical endpoint comprised death from any cause or unplanned hospitalization for a major cardiovascular event (MACE).
During the follow-up period (479 ± 252 days), 26 patients (38.8%) had reached the endpoint of MACE. In Cox proportional hazard analyses, RFP at 1 week after CRT was associated with the endpoints independently of age and New York Heart Association (NYHA) class IV at baseline. Thirty (44.8%) patients were identified as volume responders, who had better prognosis than non-responders. Patients were classified into 4 groups based on their filling pattern at 1 week after CRT and volume responses. The worst prognosis was observed in the RFP and non-responder group, and the best was observed in the non-RFP and responder group. For the remaining 2 groups with intermediate prognosis, the RFP and responder group showed poorer prognosis compared to the non-RFP and non-responder group.
Persistent RFP after CRT may be a strong prognostic predictor, which should be treated with more intensive therapy to improve the prognosis of patients following CRT.
心脏再同步治疗(CRT)可能改善左心室(LV)舒张功能障碍以及收缩功能障碍。舒张功能障碍是心力衰竭患者预后的关键因素;因此,我们旨在阐明CRT对舒张功能和预后的影响。
对67例行CRT的患者,在基线及CRT后1周通过脉冲多普勒二尖瓣血流模式评估LV舒张功能,并分为限制性充盈模式(RFP)组和非RFP组。容积反应者定义为CRT后6个月时LV收缩末期容积减少>15%。临床终点包括任何原因导致的死亡或因重大心血管事件(MACE)而进行的非计划住院。
在随访期(479±252天)内,26例患者(38.8%)达到MACE终点。在Cox比例风险分析中,CRT后1周的RFP与终点独立相关,不受基线年龄和纽约心脏协会(NYHA)IV级的影响。30例(44.8%)患者被确定为容积反应者,其预后优于无反应者。根据CRT后1周的充盈模式和容积反应将患者分为4组。RFP和无反应者组预后最差,非RFP和反应者组预后最好。对于其余2个预后中等的组,RFP和反应者组的预后比非RFP和无反应者组差。
CRT后持续的RFP可能是一个强有力的预后预测指标,应对其采用更强化的治疗以改善CRT后患者的预后。